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Abstract
Modulation of the cloned human intermediate-conductance Ca2-activated K channel (hIK) by the compound 1-ethyl-2-
benzimidazolinone (EBIO) was studied by patch-clamp technique using human embryonic kidney cells (HEK 293) stably
expressing the hIK channels. In whole-cell studies, intracellular concentrations of free Ca2 were systematically varied, by
buffering the pipette solutions. In voltage-clamp, the hIK specific currents increased gradually from 0 to W300 pA/pF
without reaching saturation even at the highest Ca2 concentration tested (300 nM). In the presence of EBIO (100 WM), the
Ca2-activation curve was shifted leftwards, and maximal currents were attained at 100 nM Ca2. In current-clamp, steeply
Ca2-dependent membrane potentials were recorded and the cells gradually hyperpolarised from 320 to 385 mV when Ca2
was augmented from 0 to 300 nM. EBIO strongly hyperpolarised cells buffered at intermediate Ca2 concentrations. In
contrast, no effects were detected either below 10 nM (no basic channel activation) or at 300 nM Ca2 (Vm close to EK).
Without Ca2, EBIO-induced hyperpolarisations were not obtainable, indicating an obligatory Ca2-dependent mechanism
of action. When applied to inside-out patches, EBIO exerted a Ca2-dependent increase in the single-channel open-state
probability, showing that the compound modulates hIK channels by a direct action on the K-subunit or on a closely
associated protein. In conclusion, EBIO activates hIK channels in whole-cell and inside-out patches by a direct mechanism,
which requires the presence of internal Ca2. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Ca2-activated K channels are almost ubiqui-
tously expressed in mammalian cells, and they link
the second messenger systems involving Ca2 to the
electrical activity of cells. Three major subtypes of
Ca2-activated K channels exist: large-conductance
(BK), intermediate-conductance (IK), and small-con-
ductance (SK) channels, which, apart from their unit
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Abbreviations: hIk, human intermediate-conductance Ca2-
activated K channel; EBIO, 1-ethyl-2-benzimidazolinone;
CLT, clotrimazole; HEPES, N-Hydroxyethylpiperazine-NP-etha-
nesulfonic acid; EGTA, ethyleneglycol-bis-(L-amino-ethylether)
N,NP-tetra-acetic acid; DMSO, dimethylsulfoxide; FCS, foetal
calf serum; DMEM, Dulbecco’s modi¢ed Eagle’s Media; HEK
293, human embryonic kidney cells ; Vm, membrane potential ;
EK, K equilibrium potential ; RS, series resistance
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conductances, also di¡er in primary structure, tissue
distribution, voltage-dependency, and Ca2-sensitiv-
ity. Furthermore, each channel subtype has a distinct
pharmacology (for a review, see [1]). The classical
selective blockers of BK and some SK channels are
the peptides iberiotoxin and apamin, respectively,
whereas the antifungal compound clotrimazole selec-
tively blocks IK channels. Compounds, which acti-
vate BK channels have been reported, and these in-
clude the plant alkaloid dihydrosoyasaponin [2] and
the substituted benzimidazolone NS1619 [3]. 1-Ethyl-
2-benzimidazolinone (EBIO) has been demonstrated
to activate the basolateral Ca2-activated K-con-
ductance in colonic T-84-derived epithelia [4], a con-
ductance entirely attributable to IK channels. The
compound also activates the recently cloned hIK
channel [5]. Activation of the basolateral Ca2-acti-
vated K-conductance is the primary mechanism for
stimulation of transepithelial Cl3 secretion by Ca2-
raising secretagogues such as acetylcholine. Gener-
ally, in secretory epithelia activation of the basolat-
eral K conductances in parallel with the luminal
cAMP-stimulated Cl3 conductance counteract the
depolarising e¡ect of Cl3 e¥ux and therefore e¡ec-
tively maintain the driving force on Cl3 during sus-
tained secretion. Therapeutically, activation of baso-
lateral K conductances may even be considered as a
mechanism for partial normalisation of secretory re-
sponses in epithelial tissue defective in CFTR [6].
Recently, clotrimazole has been shown to inhibit ac-
tivated secretion in T-84 epithelia as well as cholera
toxin-induced diarrhoea in mice, thus demonstrating
a key function of hIK channels in colonic hyperse-
cretory responses [7,8]. Clotrimazole has also been
demonstrated to reduce erythrocyte dehydration in
sickle cell patients [9] implicating a critical role of
the IK channel in the pathogenesis of sickle cell dis-
ease.
In the present study, we have investigated the ac-
tivation of the cloned hIK channel by EBIO and
show that the compound is obligatory Ca2-depend-
ent. However, EBIO strongly increases channel activ-
ity at concentrations close to the resting intracellular
levels of Ca2.
2. Materials and methods
2.1. Electrophysiology
The patch-clamp ampli¢er used was the EPC-9
(HEKA Electronics, Lambrect, Germany) controlled
by computer via an ITC-16 interface. Data were ac-
quired at 3^5 times the ¢ltration rate using the Pulse
software (HEKA-Electronics, Lambrect, Germany).
Pipettes were pulled by a DMZ-Universal Puller
(Zeitz Instrumente, Augsburg, Germany) from boro-
silicate glass (Modulohm, Copenhagen, Denmark).
For single-channel experiments, the pipettes were
coated with Sylgard and ¢re-polished to ¢nal resist-
ances in the range 1.5^3.0 M6. A custom-made
perfusion chamber (volume 15 Wl) with a ¢xed
AgCl^Ag-pellet electrode (In Vivo Metric, Healds-
burg, CA), was mounted on the stage of an inverted
microscope equipped with Nomarski interference
contrasts.
2.2. Cells
Human embryonic kidney (HEK 293) cells stably
transfected with the cDNA encoding placental hIK
were used in all experiments (cloning and basic char-
acterisation, see [5]). Cells were grown in DMEM-
media supplemented with 10% FCS and 1% genta-
mycin and were passaged twice a week. Experiments
reported in this paper were performed on passages
20^30.
2.3. Salt solutions
Extracellular: (1) standard Na solution, 140 mM
NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2 and
10 mM HEPES (pH 7.4); (2) high-K solution, 144
mM KCl, 2 mM CaCl2, 1 mM MgCl2 and 10 mM
HEPES (pH 7.4). Intracellular: (3) 144 mM KCl, 10
mM EGTA, 0^7.60 mM CaCl2, MgCl2 (1.20^5.60
mM) and 10 mM HEPES (pH 7.2). The free Ca2
concentrations, varying between approximately 50
pM (hereafter called 0 Ca2) and 300 nM as well
as the free Mg2 concentration (constant = 1.00
mM in all solutions) were calculated with Eqcal-soft-
ware (BioSoft, Cambridge, UK). EBIO was pur-
chased from Sigma. Concentrated stock solutions
were prepared in DMSO and diluted directly in the
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relevant experimental solution. The ¢nal DMSO con-
centration used was always below 0.1%, which
caused no interference with currents or membrane
potentials. All chemicals were of the purest grade
commercially available.
2.4. Experimental procedure
Coverslips containing the transfected HEK 293
cells were placed in the perfusion chamber and con-
tinuously superfused at a rate of 1 ml/min with ex-
tracellular salt solution. In the whole-cell voltage-
clamp experiments, the series resistance as well as
the cell capacitance were followed on-line. Initial ser-
ies resistances (RS) were below 5 M6 and usually
remained constant throughout the experiments. Ex-
periments were invariably discarded if RS increased
above 10 M6 or if slow capacitance cancellation
failed. All experiments were performed at room tem-
perature (21^25‡C).
3. Results
3.1. Basic experiments
The experimental protocols used for recording of
whole-cell currents from HEK 293 cells stably trans-
fected with the hIK are outlined in Figs. 1 and 2. In
the voltage-clamp experiments (Fig. 1), the cells were
always held at a membrane potential of 0 mV, and
currents were elicited by short potential steps or
ramps repeated every 5 s. Fig. 1A shows typical
ramp current responses from a cell exposed to sym-
metric K solutions, and with increasing concentra-
tions of free Ca2 in the pipette. The expressed chan-
nels concomitantly changed the cell input resistance
(from G6 to hundreds of M6) as well as the whole-
cell I^V characteristic (from linear or slightly super-
linear to inward rectifying in symmetric K solu-
tions). In Fig. 1B the currents obtained at +80 mV
has been plotted vs. the time after break-through to
the whole-cell con¢guration. At 0 Ca2 only a small
leak current was observed even after long time of
pipette/cell dialysis. However, at the higher Ca2
concentrations (30, 100, and 300 nM), the current
increased and saturated at distinct levels re£ecting
the equilibrium activation of the channels at each
Ca2 concentration. In all of the experiments de-
scribed in the following, the pipette solution was al-
lowed to equilibrate with the cell interior until a sta-
ble base-line was established (at least 3 min).
An alternative to the activation of native inter-
mediate-conductance Ca2-activated K channels
Fig. 1. HEK 293 cells stably transfected with hIK. Activation by Ca2. (A) Whole-cell currents obtained with symmetric K solutions
in response to voltage ramps. The traces are from di¡erent cells and were obtained after equilibration of the cytosol with pipette solu-
tions containing the following bu¡ered concentrations of free Ca2 : F, nominally Ca2-free (approximately 50 pM); a, 30 nM; E,
100 nM, and b, 300 nM. (B) Currents measured at 80 mV and plotted vs. the time after break-through to the whole-cell con¢gura-
tion. I^V ramps ( þ 100 mV, 1 mV/ms) were elicited at a frequency of 0.2 Hz. Holding potential : 0 mV.
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by raising intracellular Ca2 is to apply the com-
pound EBIO [4]. EBIO also activated the cloned
hIK channel, and in symmetric K solutions the
compound quickly and reversibly potentiated an in-
ward rectifying current which was similar to the cur-
rent activated by Ca2 [5].
In Fig. 2 the e¡ect of EBIO in experiments with
near physiological extracellular concentrations of
Na and K has been illustrated. In all single-dose
experiments an EBIO concentration of 100 WM was
chosen, which is close to the previously estimated
EC50 value for activation of hIK [5]. Fig. 2A shows
a typical voltage-clamp study from a cell dialysed
against a pipette solution with 65 nM Ca2. The
upper panel shows the current traces obtained by
stepping from a holding potential of 0 to 3100 and
100 mV, respectively. The control currents were
small (6 100 pA) and reversed close to 0 mV (pre-
dominantly leak current) as expected from the low
pipette Ca2 concentration. However, upon applica-
tion of EBIO the current at 0 mV increased to 1.7
nA. The EBIO-induced current was reduced to 30.2
nA by stepping to 3100 mV and augmented to 2.5
nA at 100 mV. Co-application of EBIO and the hIK
channel blocker clotrimazole completely abolished
the current. To obtain the I^V curves, the membrane
voltage was varied from 3100 to 100 mV in steps of
10 mV (lower panel). The current saturated at large
positive voltages and shifted direction from outward
to inward at a voltage close to the theoretical equi-
librium potential for K (395 mV). These results
indicate that EBIO-stimulated current maintains the
very high K/Na selectivity earlier demonstrated
for native intermediate-conductance, Ca2-activated
K channels from human erythrocytes [10] as well as
for hIK channels [5]. The instantaneous current re-
sponses obtained in the presence of EBIO shows that
the gating of the drug-modulated channel remains
voltage-independent as does the gating of hIK chan-
nels activated only by Ca2.
Fig. 2B shows a comparable current-clamp study
from another cell bu¡ered with a pipette Ca2 con-
centration of 65 nM. A relatively noisy, but stable,
membrane potential of 318 mV was initially re-
Fig. 2. HEK 293 cells stably transfected with hIK. Activation by EBIO. (A) Whole-cell voltage-clamp experiment with asymmetric
Na/K gradients (externally, solution 1; internally, solution 3 bu¡ered at 65 nM free Ca2). Upper panels : current traces obtained
by stepping from a holding potential of 0 to 3100, 0, and 100 mV, respectively. The traces in the middle panel were obtained after
superfusion with 100 WM EBIO. In the panel to the right, 1 WM clotrimazole was added to the EBIO-containing solution. Lower pan-
el : current amplitudes plotted vs. membrane potentials in the range of 3100 to 100 mV (duration, 100 ms; stimulation frequency, 0.2
Hz). R, Control; F, after application of EBIO; b, after co-application of EBIO and clotrimazole. (B) Whole-cell current-clamp ex-
periment with asymmetric Na/K gradients (as in A). EBIO was present in the bath solution during the time indicated by the bar.
The arrow indicates the shift of extracellular solution to a solution where Na was exchanged with a corresponding concentration of
K (EK = 0 mV).
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corded. Application of EBIO immediately hyperpo-
larised the cell to a new stable level at 388 mV
characterised by a much lower noise content. Upon
wash-out of EBIO the membrane potential repolar-
ised towards the original level. The membrane poten-
tial noise observed at potentials positive to the equi-
librium potential for K directly re£ects the
membrane charging/discharging e¡ects of opening
and closing individual hIK channels. Accordingly,
the noise also disappeared after superfusion with
the high K solution which make EK = 0.
Control recordings with naive HEK 293 cells
showed that neither high intracellular Ca2 nor
superfusion with EBIO activated hyperpolarising
currents (not shown).
3.2. Ca2+-dependency of EBIO modulation
To test the e⁄cacy of EBIO as an hIK activator
under controlled levels of channel activation, we
studied the compound at various levels of intracellu-
lar free Ca2 as set by the concentrations in the
Ca2-bu¡ered pipette solutions. Fig. 3A shows typi-
cal ramp current traces obtained before and after
application of a ¢xed concentration of EBIO (100
WM) at 0, 30 and 300 nM intracellular Ca2, respec-
tively. Note, that the scalings of the current axes
varies strongly in order to emphasise the e¡ect of
EBIO at the di¡erent Ca2 concentrations. In the
experiment with 0 Ca2, no basic hIK channel activ-
ity was observed as judged from the very small (35
pA at 80 mV) and essentially linear I^V relation,
which basically re£ects the I^V relation of the naive
HEK 293 cell clone used for transfection. Applica-
tion of EBIO under these conditions neither in£u-
enced the size of the current nor the shape of the
I^V curve. At 30 nM Ca2, a signi¢cant current
was recorded (0.1 nA at 80 mV), and the weak in-
ward recti¢cation characterising hIK was evident. At
this Ca2 concentration, EBIO strongly activated the
Fig. 3. Ca2-dependency of EBIO modulation of hIK. (A) E¡ect of 100 WM EBIO on ramp currents obtained after equilibration with
pipette solutions (solution 3) bu¡ered at 0, 30, and 300 nM free Ca2, respectively. The pipette solutions were allowed to equilibrate
at least 3 min before application of EBIO. Note, that the current traces have been normalised to clarify the relative e¡ects of the com-
pound at the di¡erent Ca2 concentrations. Stimulation protocols as described in legend to Fig. 1. (B) Histograms summarising the
levels of stationary whole-cell currents (measured at 80 mV) obtained at the various concentrations of bu¡ered intracellular free Ca2
in the range of 0^300 nM before (left panel) and after EBIO application (right panel). All currents were normalised with respect to
cell size (pA/pF). Error bars represents S.E.M.; n is between 6 and 8 for each Ca2 concentration.
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current (to 0.6 nA at 80 mV). At 300 nM Ca2, the
basic level of hIK activation was high and gave rise
to an outward current of 3 nA at 80 mV. Even at this
level of activation, EBIO application more than dou-
bles the hIK speci¢c current. In Fig. 3B, the mean
whole-cell currents normalised with respect to cell
size (pA/pF) has been plotted as a function of the
intracellular Ca2 concentration in absence (left) and
in presence of EBIO (right). The basic hIK current
increased as a function of intracellular Ca2 with an
apparent threshold for activation below 30 nM, and
with no tendency to saturation even at 300 nM intra-
cellular Ca2. Attempts to obtain the full dose^re-
sponse curve for Ca2 activation by equilibration
with higher Ca2 concentrations was generally un-
successful, mainly due to problems with increasing
series resistances during experiments. In presence of
EBIO, the hIK currents were strongly increased at all
concentrations of Ca2 above 30 nM, and in contrast
to the control experiments, the Ca2 dose^response
relation approached saturation already at 100 nM
Ca2. However, there was no e¡ect of EBIO at
0 Ca2, indicating that the ability of EBIO to stim-
ulate hIK currents in the whole-cell con¢guration is
strongly Ca2-dependent.
The interactions of EBIO and Ca2 on hIK was
quanti¢ed by current-clamp recordings with asym-
metric ion gradients of Na and K. Fig. 4A shows
examples of such recordings with 0, 30 and 300 nM
pipette Ca2. Giga-sealing and establishment of the
whole-cell con¢guration was done in the high K
extracellular solution, and the initial membrane po-
tential read-out was therefore close to zero in all
experiments. Upon changing to the standard extra-
cellular Na solution, a negative basic membrane po-
tential quickly developed. At 0 and 30 nM Ca2 al-
most identical potentials around 320 mV developed,
whereas the cell equilibrated with 300 nM hyperpo-
Fig. 4. Ca2 and EBIO induced hyperpolarisations of hIK-transfected HEK 293 cells. (A) Recording of the membrane potentials
from cells dialysed with pipette solutions (solution 3) bu¡ered at 0, 30, and 300 nM Ca2, respectively. The cells were initially super-
fused with the high extracellular K solution (solution 2) in which the electrodes were zeroed. After 2 min of recording (arrows), the
high K solution was exchanged with the standard extracellular Na solution (solution 1). After 4 min, the cells were superfused with
extracellular Na solution containing 100 WM EBIO (indicated by the bars). (B) Summary of membrane potentials recorded after
equilibration with pipette solutions containing 0, 10, 30, 100, and 300 nM Ca2, respectively. The stationary membrane potentials was
recorded in the absence (left panel) and presence of 100 WM EBIO (right panel). Error bars represents S.E.M.; n is between 6 and 9
for each Ca2 concentration.
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larised to 387 mV. No hyperpolarising e¡ect of
EBIO was observed at 0 Ca2, whereas the cell equi-
librated with 30 nM Ca2 responded to EBIO with
an additional hyperpolarisation to 348 mV. In the
cell equilibrated with 300 nM Ca2, the basic mem-
brane potential was close to the equilibrium potential
for potassium and, therefore, no additional hyperpo-
larisation was obtained with EBIO. Fig. 4B summa-
rises the stable membrane potentials obtained at the
various intracellular Ca2 concentrations in the ab-
sence (left) and presence (right) of EBIO. In both
cases, the membrane potentials raised steeply from
limiting potentials of W320 mV (318.4 þ 2.8 vs.
319.4 þ 2.5 mV) at 0 Ca2 to more than 380 mV
(384.0 þ 0.5 vs. 384.6 þ 0.3 mV) at 300 nM Ca2.
The overall e¡ect of EBIO was to leftward shift the
membrane potential vs. intracellular Ca2 curve, (the
half maximal hyperpolarisation value was below 30
nM Ca2 in presence of 100 WM EBIO). However,
no hyperpolarising e¡ect of EBIO was ever observed
below 10 nM Ca2, indicating that the compound
mediates Ca2-dependent hyperpolarisation of hIK-
transfected HEK 293 cells.
High EBIO concentrations might trigger the hIK
channels to open and hyperpolarise the cell mem-
brane even in the virtual absence of Ca2. Fig. 5A
shows typical current-clamp recordings with cells
equilibrated with 30 nM pipette Ca2 (left) and 0
Ca2 (right), respectively. With 30 nM Ca2 a basic
membrane potential of 325 mV was recorded.
Superfusion with increasing EBIO concentrations in
the range of 10 WM to 1 mM gradually hyperpolar-
ised the cell. A signi¢cant hyperpolarisation occurred
even at 10 WM (to 338 mV) and the maximal e¡ect
(to 383 mV) was attained at 300 WM. Remarkably,
the wash-out of EBIO was fast and complete even
after exposure to the highest concentration of 1 mM.
Note, that the membrane potential oscillations
present in this experiment re£ect local concentration
changes of EBIO in the experimental chamber during
the solution shift. In the experiment with 0 Ca2, the
basic membrane potential was 311 mV and there
Fig. 5. EBIO dose^response experiments. (A) Current-clamp recordings showing the e¡ect of increasing concentrations of EBIO on
hIK-transfected cells. The pipette solutions were bu¡ered at 30 (right panel) and 0 nM (left panel) Ca2, respectively. The arrows indi-
cate shifts from the high K extracellular solution (solution 2) to the standard extracellular Na solution (solution 1) and back again.
(B) Summary of membrane potential recordings with increasing concentrations of EBIO in a series of cells bu¡ered at 30 nM Ca2
(n = 6) and a series of cells bu¡ered at 0 Ca2 (n = 6). Experimental details as outlined in A.
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was no e¡ect of superfusion with increasing concen-
trations of EBIO. Fig. 5B summarises the results
from these series of experiments. At 30 nM internal
Ca2, a mean basic membrane potential of
323.5 þ 2.4 mV and a maximally EBIO (1 mM)
stimulated membrane potential of 379.7 þ 2.5 mV
were found. At 0 Ca2 the basic membrane potential
was 313.5 þ 3.6 mV and the membrane potentials
recorded in presence of 1 mM EBIO 317.4 þ 2.9
mV, indicating no signi¢cant activation of the chan-
nels.
3.3. Single-channel recordings
To demonstrate that EBIO acts directly on the
channel or a closely associated accessory protein
rather than via a receptor/second-messenger system,
we performed single-channel recordings using excised
inside-out patches. Fig. 6 shows the e¡ect of EBIO
on single-channels from inside-out patches exposed
to 0 or 300 nM Ca2 at the inside solution. Distinct
single-channel gating events from at least three chan-
nels were observed in the patch exposed to 300 nM
Ca2. Upon superfusion with EBIO (100 WM), the
patch currents dramatically increased to a noisy cur-
rent demonstrating the presence of multiple channels
in the patch. Simultaneous application of EBIO and
clotrimazole (1 WM) completely eliminated the noisy
current, indicating that the EBIO-stimulated hIK
channels maintain their basic sensitivity to clotrima-
zole. In the experiment with 0 Ca2 (Fig. 6B), very
few openings occurred (most likely representing gat-
ing events from endogenous HEK 293 channels) and
neither the frequency nor the duration of these
events were a¡ected by superfusion with EBIO.
4. Discussion
The conditions for activation of the cloned hIK by
EBIO was studied using HEK 293 cells stably ex-
pressing hIK channels.
Intracellular concentrations of free Ca2 were var-
ied in the range from 0 to 300 nM to study the
Fig. 6. EBIO modulation of single hIK channels. (A) A multichannel recording from an inside-out patch clamped at 3100 mV. The
patch was exposed to symmetrical K solutions (solution 3 bu¡ered at 300 nM Ca2). The expanded trace represents 1 s of recording
and reveals up to three distinct single-channel current levels of 33.8 pA each. EBIO (100 WM) was applied to the bath after 30 s (low-
er bar) and clotrimazole (1 WM) was applied together with EBIO after 60 s. (B) No e¡ect of EBIO applied to an inside-out patch
superfused with solution 3 bu¡ered at 0 Ca2. All traces were ¢ltered at 300 Hz and acquired at a sample rate of 1000 points/s.
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e⁄cacy of EBIO at di¡erent basic levels of channel
activation, and especially to elucidate whether chan-
nel activation might be induced by the compound
itself or only in concert with Ca2. Basic hIK char-
acteristic currents (inward-rectifying, time-independ-
ent, K-selective, clotrimazole-sensitive) developed
gradually towards stable levels after break-through
to the whole-cell mode. The plateau currents in-
creased from 3 þ 1.6 to 315 þ 54.5 pA/pF (measured
at 80 mV) without showing saturation, even at 300
nM Ca2. However, in presence of 100 WM EBIO the
hIK current vs. Ca2-activation curve shifted to-
wards lower Ca2 concentrations and saturation
was attained already at 100 nM Ca2. No EBIO-
stimulated current was observed at 0 Ca2. The
membrane potentials recorded in near-physiological
transmembrane ion gradients were steeply Ca2-de-
pendent, varying between 315 and 320 mV in the
limit of low Ca2 concentrations and 380 to 385
mV at 300 nM, indicating a dominating Ca2-de-
pendent K channel contribution to the total mem-
brane conductance. EBIO at 100 WM strongly hyper-
polarised cells at Ca2-concentrations between 30
and 100 nM. At 300 nM Ca2, where the basic mem-
brane potential was already close to the equilibrium
potential for K, EBIO could not hyperpolarise the
cells any further. At 0 Ca2, EBIO-induced hyper-
polarisations were even not obtainable at EBIO con-
centrations as high as 1 mM. In contrast, at 30 nM
Ca2 EBIO hyperpolarised the membrane in the low
WM concentration range. Therefore, the overall ac-
tion of EBIO on the cloned channel is not to act as a
gating molecule per se. In whole cells, EBIO e¡ec-
tively induces a left-shifting of the Ca2-activation
curve. It remains to be settled if this e¡ect, at the
molecular level, represents a modi¢cation of the
Ca2 binding properties of hIK. In this respect, it
is noteworthy that Ca2 binding is di¡erent in nature
among the three classes of Ca2-activated K chan-
nels. The BK channel K-subunit forms a genuine
binding-site for Ca2 [11] and is perfectly capable
of performing Ca2-dependent gating, whereas the
SK K-subunits have no such site and combine con-
stitutively with calmodulin to obtain its Ca2-de-
pendency [12]. A recently published paper [13] indi-
cates that the gating of hIK also depends on Ca2
binding to tightly bound calmodulin. Therefore, it
cannot be excluded that EBIO improves calmodulin
Ca2 binding and/or the calmodulin^channel interac-
tion.
EBIO was originally studied for its e¡ects on the
short circuit currents through cultured T-84 epithelia,
a model for colonic NaCl/water secretion, and the
e¡ects were con¢rmed in intact murine colonic epi-
thelium [14]. The EBIO-stimulated secretion was
blocked dose-dependently by charybdotoxin as well
as by clotrimazole [8]. Patch-clamp studies clearly
showed that the e¡ect of the compound was to in-
crease the activity of the basolateral, inward rectify-
ing, intermediate-conductance, Ca2-activated K
channel, thus resembling the e¡ect of Ca2 mobilis-
ing secretagogues, like carbachol and taurodeoxycho-
late [15]. However, the stimulatory e⁄cacy of EBIO
was found to be superior to raising intracellular Ca2
[4]. Therefore, it was suggested that the compound
acted by increasing in parallel the luminal cAMP-
dependent Cl3 conductance as well as the basolateral
Ca2-dependent K conductance, thus enabling an
enhanced and prolonged secretory response. EBIO
increased the open state probability of the K chan-
nels in inside-out patches, indicating that the e¡ect
was exerted via a direct action on the channel protein
rather than via a secondary mechanism involving
Ca2 or another second messenger molecule. The
EBIO stimulation observed in inside-out patches
was also shown to be Ca2-dependent, since the ef-
fect disappeared by lowering the Ca2 concentration
from 200 nM to zero [14].
Despite the clear Ca2-dependence of the EBIO
e¡ect, it is obvious that EBIO is e¡ective at Ca2
concentrations close to or even below the resting
level of intracellular Ca2. At this concentration
range of Ca2, the open-state probability of hIK
channels is low [15]. This indicates that EBIO ^ or
a compound with a similar mechanism of action ^
might be an extremely e¡ective way of hyperpolaris-
ing cells expressing hIK, even without a concurrent
cytosolic Ca2 increase. The powerful activating ef-
fect of EBIO on the short-circuit current in otherwise
unstimulated secretory epithelia, indicates that the
basic intracellular Ca2 concentration close to the
basolateral membrane is su⁄cient to sustain EBIO
activation of the Ca2-activated K conductance.
The Ca2 sensitivity of EBIO action on hIK di¡ers
qualitatively from the mechanism by which com-
pounds, such as the benzimidazolone, NS1619 and
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the substituted diphenylurea, NS1608, activates the
BK channel subtype of Ca2-activated K channels
[16]. Activation of BK channels by these compounds
was demonstrated to be a Ca2-independent process
characterised by a dose-dependent leftward shift of
the voltage activation curve. We found no activating
e¡ect of NS1608 and NS1619 on hIK at concentra-
tions, which activate BK channels (not shown). Con-
sistent with these ¢ndings, NS1619 has recently been
shown to exert a blocking e¡ect on the intermediate-
conductance Ca2-activated K channel in aortic en-
dothelial cells [17] at concentrations above 10 WM.
Furthermore, we did not ¢nd any e¡ect of EBIO on
the cloned BK channels (not shown).
The mechanistic similarity between the e¡ects of
EBIO on the cloned hIK and on the native IK chan-
nels strengthens the notion that the cloned hIK is
identical to or closely related to the basolateral
Ca2-activated K channels of intermediate-conduct-
ance present in colonic epithelia. The cloned hIK
may therefore constitute a relevant molecular target
for the focused development of new drugs acting on
this channel. hIK is almost exclusively expressed out-
side excitable tissues and predominantly in epithelia
and blood cells [5,15,18]. Therefore, a therapeutic
application for openers of this channel may be var-
ious secretory disorders, such as cystic ¢brosis (de-
creased airway and intestinal secretion) and SjÖgrens
syndrome (decreased saliva secretion).
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